Balyasny Asset Management’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-580,574
Closed -$35M 1481
2016
Q2
$35M Sell
580,574
-464,986
-44% -$26.4M 0.23% 112
2016
Q1
$48.1M Buy
1,045,560
+951,301
+1,009% +$34.5M 0.29% 91
2015
Q4
$4.56M Sell
94,259
-119,595
-56% -$5.16M 0.03% 516
2015
Q3
$9.09M Buy
+213,854
New +$10.6M 0.07% 367
2014
Q3
Sell
-119,000
Closed -$4.59M 989
2014
Q2
$4.59M Buy
+119,000
New +$4.01M 0.05% 400
2014
Q1
Sell
-152,422
Closed -$4.86M 781
2013
Q4
$4.86M Buy
+152,422
New +$4.61M 0.06% 311
2013
Q3
Sell
-470,120
Closed -$13.4M 836
2013
Q2
$11.6M Buy
+470,120
New +$11.8M 0.19% 125

Other funds holding MDVN

Balyasny Asset Management's MDVN Position: Q3 2016 in Review

Balyasny Asset Management sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 580,574 shares — an estimated $35M sold.

Balyasny Asset Management first reported a position in MDVN in Q2 2013 and held it in 7 quarters. The position peaked at $48.1M in Q1 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Balyasny Asset Management reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Balyasny Asset Management sold 580,574 MEDIVATION, INC. shares in Q3 2016, an estimated $35M.
  • Balyasny Asset Management first reported a position in MEDIVATION, INC. in Q2 2013 and held it in 7 quarters.
  • Balyasny Asset Management's MEDIVATION, INC. position peaked at $48.1M in Q1 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Balyasny Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.